secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q/C TECHNOLOGIES, INC. (QCLS)
CIK:        0001321834
Form:       8-K
Filed at:   2024-09-23T23:59:59+00:00
Accession:  0001493152-24-037819
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.08
LLM model:  deepseek-v4-flash:cloud@v2

TNF Pharmaceuticals sets 2024 annual meeting for Nov 25; deadlines for proposals and nominations announced
--------------------------------------------------------------------------------

- 2024 annual meeting scheduled for November 25, 2024; record date October 18, 2024.
- Stockholder proposals for inclusion in proxy under Rule 14a-8 must be received by October 3, 2024.
- Nominations and other business outside Rule 14a-8 must be submitted by October 3, 2024.
- Universal proxy rule notices for non-company nominees also due by October 3, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1321834/000149315224037819/0001493152-24-037819-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1321834/000149315224037819/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-037819

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer